These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Employing virtual screening and molecular dynamics simulations for identifying hits against the active cholera toxin. Gangopadhyay A; Chakraborty HJ; Datta A Toxicon; 2019 Dec; 170():1-9. PubMed ID: 31494206 [TBL] [Abstract][Full Text] [Related]
8. Conformations of higher gangliosides and their binding with cholera toxin - investigation by molecular modeling, molecular mechanics, and molecular dynamics. Sharmila DJ; Veluraja K J Biomol Struct Dyn; 2006 Jun; 23(6):641-56. PubMed ID: 16615810 [TBL] [Abstract][Full Text] [Related]
9. Sialic acid recognition by Vibrio cholerae neuraminidase. Moustafa I; Connaris H; Taylor M; Zaitsev V; Wilson JC; Kiefel MJ; von Itzstein M; Taylor G J Biol Chem; 2004 Sep; 279(39):40819-26. PubMed ID: 15226294 [TBL] [Abstract][Full Text] [Related]
10. Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin. Zaccai NR; Maenaka K; Maenaka T; Crocker PR; Brossmer R; Kelm S; Jones EY Structure; 2003 May; 11(5):557-67. PubMed ID: 12737821 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Merritt EA; Sarfaty S; van den Akker F; L'Hoir C; Martial JA; Hol WG Protein Sci; 1994 Feb; 3(2):166-75. PubMed ID: 8003954 [TBL] [Abstract][Full Text] [Related]
12. Monosialogangliosides and their interaction with cholera toxin - investigation by molecular modeling and molecular mechanics. Sharmila DJ; Veluraja K J Biomol Struct Dyn; 2004 Feb; 21(4):591-614. PubMed ID: 14692802 [TBL] [Abstract][Full Text] [Related]
13. Identification of inhibitors against the potential ligandable sites in the active cholera toxin. Gangopadhyay A; Datta A Comput Biol Chem; 2015 Apr; 55():37-48. PubMed ID: 25698576 [TBL] [Abstract][Full Text] [Related]
14. Insights into binding of cholera toxin to GM1 containing membrane. Basu I; Mukhopadhyay C Langmuir; 2014 Dec; 30(50):15244-52. PubMed ID: 25425333 [TBL] [Abstract][Full Text] [Related]
15. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations. Shamim A; Abbasi SW; Azam SS J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477 [TBL] [Abstract][Full Text] [Related]
16. Physicochemically stable cholera toxin B subunit pentamer created by peripheral molecular constraints imposed by de novo-introduced intersubunit disulfide crosslinks. Miyata T; Oshiro S; Harakuni T; Taira T; Matsuzaki G; Arakawa T Vaccine; 2012 Jun; 30(28):4225-32. PubMed ID: 22542816 [TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulations of alpha2 --> 8-linked disialoside: conformational analysis and implications for binding to proteins. Vasudevan SV; Balaji PV Biopolymers; 2002 Mar; 63(3):168-80. PubMed ID: 11787005 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of kinetic parameters for the binding of cholera toxin to immobilized sialic acid and monoclonal antibody using an array biosensor. Ngundi MM; Taitt CR; Ligler FS Biosens Bioelectron; 2006 Jul; 22(1):124-30. PubMed ID: 16431098 [TBL] [Abstract][Full Text] [Related]
19. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase. Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517 [TBL] [Abstract][Full Text] [Related]
20. Unveiling the Anti-Cholera and Active Diabetic Renoprotective Compounds of Maqian Essential Oil: A Computational and Molecular Dynamics Study. Dahab M; Zhang P; Al-Mijalli SH; Abdallah EM Molecules; 2023 Dec; 28(24):. PubMed ID: 38138443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]